Loading…
Attending this event?
AS

Andrew Stelzer

Unlearn.ai, United States
Head of Business Development
Andrew is a business development expert in the biotechnology and pharmaceutical industries. Most recently, he supported NewCo formation and translational efforts at The Salk Institute for Biological Studies. Prior to Salk, Andrew developed the partnering strategy for InSphero, a Swiss biotechnology company spun out of ETH Zurich, and co-founded Nymirum, a private venture backed biotechnology company, spun out of the University of Michigan. Andrew holds a Ph.D. in Biophysics and Chemical Biology from the University of Michigan and a B.S. in Chemistry from the University of Toledo.

My Speakers Sessions

Monday, June 17
 

11:00am PDT

#106: Machine Learning and Simulations to Facilitate Clinical Trials Room 5AB
 
Share Modal

Share this link via

Or copy link